Doxorubicin-paclitaxel: A safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European organization for research and treatment of cancer multicenter trial

Laura Biganzoli, Tanja Cuter, Peter Bruning, Robert E. Coleman, Luc Duchateau, Bernardo Rapoport, Marianne Nooij, François Delhaye, D. Miles, Aaron Sulkes, A. Hamilton, Martine Piccart

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Doxorubicin-paclitaxel: A safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European organization for research and treatment of cancer multicenter trial'. Together they form a unique fingerprint.

Medicine & Life Sciences